Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL5612725 | 0.96 | CYP2A6 (0.42) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL24789511 | 0.83 | CYP1A2 (0.50) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL5638671 | 0.79 | ALDH1A1 (0.44) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL29360084 | 0.76 | CYP1A2 (0.56) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL119090 | 0.76 | CYP1A2 (0.56) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL5575751 | 0.75 | CYP1A2 (0.41) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL21360527 | 0.75 | HSD17B10 (0.42) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL28178967 | 0.74 | CYP1A2 (0.54) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL27879112 | 0.74 | CYP1A2 (0.54) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| Hydrogen Sulfide SCHEMBL27306888 | 0.74 | CYP1A2 (0.54) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10400003-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-09-03 | — | — | US | disclosed |
| US-20180141969-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10400003-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | CYP2A6 1419/4885CYP1A2 428/4885TSHR 3663/4885 |
| US-20180141969-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | ORC3, LEF1, OCIAD1 | CYP2A6 1419/4885CYP1A2 428/4885TSHR 3663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.